SenesTech, Inc. (SNES)

Market Cap	9.17M +205.8%
Revenue (ttm)	2.30M +39.4%
Net Income	-5.83M
EPS	-2.62
Shares Out	5.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,157
Open	1.780
Previous Close	1.780
Day's Range	1.660 - 1.790
52-Week Range	1.300 - 6.240
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 11, 2026

About SNES

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient ...

• Industry: Specialty Chemicals
• Sector: Materials
• IPO Date: Dec 8, 2016
• Employees: 23
• Stock Exchange: NASDAQ
• Ticker Symbol: SNES
• Website: https://www.senestech.com

Financial Performance

In 2024, SenesTech's revenue was $1.86 million, an increase of 55.66% compared to the previous year's $1.19 million. Losses were -$6.18 million, -19.79% less than in 2023.